Inventor · disambiguated record
Nick Knudsen
Also filed as: KNUDSEN NICK
37 granted patents·9 pending applications·455 citations·filing 2005–2023
98Inventor score
Top patents by PatentIndex Score
46 records- 0198US8012931B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2008·Granted Sep 6, 2011·76 cites·52 claims
- 0296US10253083B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted Apr 9, 2019·11 cites·20 claims
- 0396US8383365B2Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivativesAMBRX INC·Filed 2011·Granted Feb 26, 2013·48 cites·60 claims
- 0496US7947473B2Methods for expression and purification of pegylated recombinant human growth hormone containing a non-naturally encoded keto amino acidAMBRX INC·Filed 2008·Granted May 24, 2011·25 cites·4 claims
- 0595US10751391B2Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acidAMBRX INC·Filed 2019·Granted Aug 25, 2020·6 cites·24 claims
- 0695US8735539B2Relaxin polypeptides comprising non-naturally encoded amino acidsKRAYNOV VADIM·Filed 2011·Granted May 27, 2014·36 cites·58 claims
- 0794US10702588B2Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chainAMBRX INC·Filed 2018·Granted Jul 7, 2020·7 cites·20 claims
- 0894US10550190B2Phosphate based linkers for intracellular delivery of drug conjugatesMERCK SHARP & DOHME·Filed 2015·Granted Feb 4, 2020·13 cites·4 claims
- 0994US9975936B2Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2016·Granted May 22, 2018·12 cites·20 claims
- 1094US9567386B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2013·Granted Feb 14, 2017·14 cites·12 claims
- 1194US9079971B2Modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2013·Granted Jul 14, 2015·19 cites·39 claims
- 1294US8178108B2Methods for expression and purification of recombinant human growth hormoneBUECHLER YING·Filed 2007·Granted May 15, 2012·32 cites·5 claims
- 1393US9517273B2Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2015·Granted Dec 13, 2016·15 cites·20 claims
- 1493US8080391B2Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymerBUECHLER YING·Filed 2005·Granted Dec 20, 2011·16 cites·8 claims
- 1593US7959926B2Methods for expression and purification of recombinant human growth hormone mutantsAMBRX INC·Filed 2007·Granted Jun 14, 2011·24 cites·4 claims
- 1692US9962450B2Method of treating heart failure with modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted May 8, 2018·9 cites·21 claims
- 1792US8329869B2Modified interferon beta polypeptides and their usesKRAYNOV VADIM·Filed 2012·Granted Dec 11, 2012·21 cites·6 claims
- 1891US9452222B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2014·Granted Sep 27, 2016·14 cites·19 claims
- 1990US11773150B2Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 3, 2023·2 cites·7 claims
- 2090US8114630B2Modified interferon beta polypeptides and their usesKRAYNOV VADIM·Filed 2008·Granted Feb 14, 2012·18 cites·4 claims
- 2189US8093356B2Pegylated human interferon polypeptidesHAYS ANNA-MARIA A·Filed 2007·Granted Jan 10, 2012·19 cites·5 claims
- 2287US2024189392A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2023·Application pending·0 cites
- 2386US10961291B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2019·Granted Mar 30, 2021·1 cites·26 claims
- 2484US11510993B2Antibody drug conjugate for anti-inflammatory applicationsMERCK SHARP & DOHME·Filed 2016·Granted Nov 29, 2022·3 cites·20 claims
- 2584US10377805B2Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their usesAMBRX INC·Filed 2018·Granted Aug 13, 2019·2 cites·21 claims
- 2684US8946148B2Modified insulin polypeptides and their usesMIAO ZHENWEI·Filed 2008·Granted Feb 3, 2015·6 cites·3 claims
- 2781US11786578B2Modified relaxin polypeptides and their usesAMBRX INC·Filed 2022·Granted Oct 17, 2023·0 cites·19 claims
- 2881US2023028168A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2022·Application pending·0 cites
- 2977US11993637B2Modified FGF-21 polypeptides with non-naturally encoded amino acidsAMBRX INC·Filed 2021·Granted May 28, 2024·0 cites·20 claims
- 3075US10800856B2Prostate-specific membrane antigen antibody drug conjugatesAMBRX INC·Filed 2013·Granted Oct 13, 2020·2 cites·5 claims
- 3175US2023348547A1Modified bovine g-csf polypeptides and their usesAMBRX INC·Filed 2022·Application pending·0 cites
- 3274US9938333B2Modified leptin polypeptides and their usesKRAYNOV VADIM·Filed 2009·Granted Apr 10, 2018·2 cites·9 claims
- 3373US11311605B2Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptidesAMBRX INC·Filed 2020·Granted Apr 26, 2022·0 cites·24 claims
- 3472US11439710B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2020·Granted Sep 13, 2022·0 cites·20 claims
- 3571US10138283B2Modified bovine G-CSF polypeptides and their usesHAYS PUTNAM ANNA MARIA A·Filed 2009·Granted Nov 27, 2018·2 cites·4 claims
- 3669US2023099074A1Antibody drug conjugate for anti-inflammatory applicationsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3768US11459392B2Anti-CD70 antibody drug conjugatesAMBRX INC·Filed 2018·Granted Oct 4, 2022·0 cites·16 claims
- 3866US11542310B2Modified bovine G-CSF polypeptides and their usesAMBRX INC·Filed 2018·Granted Jan 3, 2023·0 cites·6 claims
- 3956US10208123B2Anti-CD70 antibody drug conjugatesAMBRX INC·Filed 2013·Granted Feb 19, 2019·0 cites·4 claims
- 4052US2015299288A1Modified Insulin Polypeptides and Their UsesAMBRX INC·Filed 2014·Application pending·0 cites
- 4151US2010135959A1Human Interferon Molecules and Their UsesAMBRX INC·Filed 2006·Application pending·0 cites
- 4251US2011178029A1Modified Human Apolipoprotein A-1 and Their UsesAMBRX INC·Filed 2008·Application pending·0 cites
- 4345US10800826B2Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 13, 2020·0 cites·10 claims
- 4443US2015152187A1Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand PolypeptidesAMBRX INC·Filed 2013·Application pending·0 cites
- 4540US10105447B2Method of treating obesity in a companion animal comprising administering a modified canine leptin polypeptideELANCO US INC·Filed 2014·Granted Oct 23, 2018·0 cites·5 claims
- 4638US2012283172A1Modified porcine somatotropin polypeptides and their usesWALLEN III JOHN W·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nick Knudsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →